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Introduction
Cellular senescence has predominantly been characterized using 
fibroblast models, where it is defined as the irreversible loss of pro-
liferative capacity despite continued viability and metabolic activ-
ity (1). This arrested cell division arises as a consequence of either 
telomere-dependent or telomere-independent pathways, the lat-
ter being induced as a result of DNA damage by reactive oxygen 
species (ROS) or the activation of cellular stress pathways (1, 2). 
Another defining feature of fibroblast senescence is the acqui-
sition of a senescence-associated secretory phenotype (SASP), 
featuring the secretion of growth factors, proteases, and inflam-
matory cytokines that affect neighboring cells in a paracrine man-
ner (3). Therefore, senescent cells still have to fulfill the energy 
requirements for these functions.
It is not clear exactly how senescence manifests itself in T 
lymphocytes. Like fibroblasts, these cells are highly proliferative, 
and in response to repeated stimulation, they also experience 
growth arrest (4–6). It has been proposed that senescent human 
T cells lose expression of the costimulatory receptor CD28, exhibit 
increased expression of surface KLRG1 and/ or CD57, have short 
telomeres associated with low telomerase activity, and show a 
decreased capacity for expansion after activation (7–9). Func-
tional data examining the mechanisms of senescence have pre-
dominately used the loss of CD28 expression to define senescent 
T cells; however, the CD28– population is very heterogeneous and 
encompasses both effector and senescent cells (10, 11). However, 
more definitive characteristics of senescence, including markers 
of the DNA damage response and p38 MAPK activation, have not 
been investigated in parallel with KLRG1 and CD57. The first aim 
of the present study was to combine multiple markers of senes-
cence to characterize which primary human CD8+ T cells have 
characteristics of senescence.
In rodents, effector T cells preferentially engage glycolysis 
over oxidative phosphorylation (OXPHOS) to generate the energy 
required for functional activity, despite the fact that the former 
process is much less efficient at generating ATP from glucose 
(12). However, it is not known how senescent human CD8+ T cells 
generate the energy required for their functional activity. Further-
more, previous studies have shown that blocking p38 signaling 
can reverse some senescence-associated defects in human T cells, 
such as low proliferation and telomerase activity after stimulation 
(13). However, it is not known how the extra energy required for 
these functions is generated. p38 is activated both by environmen-
tal stressors, such as DNA damage, and by ROS and proinflam-
matory cytokines, via a canonical signaling pathway involving a 
kinase activation cascade that culminates in the phosphorylation 
of p38 MAPK (14). In T cells, there is an alternative pathway that 
directly couples TCR ligation to p38 activation, allowing T cells to 
activate p38 under nonstressful conditions (15). p38 also plays an 
important role in senescence growth arrest due to its ability to acti-
vate both the p53 and pRb/p16 growth arrest pathways (16); how-
ever, its role in regulating T cell metabolism is not known.
In the present study, we found that effector memory CD8+ 
T cells that reexpress CD45RA (EMRA) exhibited multiple charac-
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indicates that they have experienced more cycles of proliferation. 
We found that the EMRA CD8+ T cells had the lowest telomerase 
activity after activation (Figure 1B).
p38 MAPK is activated in response to DNA damage and plays 
a central role in inducing senescence due to its ability to activate 
both p53 and pRb/p16 pathways (16, 23). The high expression 
levels of phosphorylated p38 (p-p38) MAPK were detected in the 
EMRA subset after stimulation, as determined by Western blot 
and flow cytometric analysis (Figure 1, C and D). ROS can induce 
DNA damage and senescence by activating p53 (2). We found that 
production of both mitochondrial and cytoplasmic ROS (mea-
sured by MitoSOX and DHE, respectively) were significantly high-
er in EMRA CD8+ T cells compared with all other subsets (Figure 1, 
E and F, and Supplemental Figure 1B).
The key attribute and defining feature of senescence is growth 
arrest, and we found that EMRA CD8+ T cells showed significantly 
less proliferative activity after activation than the other subsets 
(Figure 1G). Despite this, these cells had potent effector activity 
— as shown by their greater polyfunctionality, measured by flow 
cytometry (TNF-α, IFN-γ, perforin, and granzyme per cell) — com-
pared with the other subsets (Figure 1H). Therefore, EMRA CD8+ 
T cells have multiple phenotypic and functional characteristics of 
cellular senescence, including low proliferative activity, but have 
the characteristics of potent effector T cells.
EMRA CD8+ T cells exhibit mitochondrial impairment. The 
increased level of ROS in the senescent CD8+ T cell population 
raised the possibility that there were alterations in mitochondrial 
function in these cells. We therefore examined the mitochondria 
in the CD8+ T cell subsets, stimulated overnight with anti-CD3 
and IL-2, by electron microscopy (Figure 2A). We observed signifi-
cantly fewer mitochondria in EMRA CD8+ T cells compared with 
the other memory subsets using a point counting method to quan-
titate these organelles (Figure 2B). We also stained stimulated 
CD8+ T cells with MitoTracker Green, a mitochondrial-specific 
dye that binds the mitochondrial membranes independently of 
mitochondrial membrane potential (MMP), which has been used 
as a quantitative assessment of mitochondrial mass (24). Mito-
chondrial mass was highest in CM and EM CD8+ T cells, and the 
EMRA subset displayed a significantly lower mitochondrial mass 
than EM CD8+ T cells (Figure 2, C and D). We further confirmed 
the lower mitochondrial content in EMRA CD8+ T cells by exam-
ining the ratio of mitochondrial DNA to nuclear DNA (mtDNA/
nDNA), which also confirmed that EMRA CD8+ T cells displayed 
significantly less mitochondrial mass than the CM and EM subsets 
(P < 0.05; Figure 2E). The lower mitochondrial content in the acti-
vated EMRA CD8+ T cells was not due to the unresponsiveness of 
these cells, as no significant difference in expression of the activa-
tion marker CD69 was found among all 4 subsets after stimulation 
(Supplemental Figure 2, A–C).
We next investigated mitochondrial function by examining 
MMP in different subsets in freshly isolated PBMCs, after over-
night stimulation with anti-CD3 antibody, using the lipophilic 
cation JC-1 (Figure 2, F and G). JC-1 is mitochondria selective 
and forms aggregates in polarized mitochondria that result in a 
green-orange emission after excitation. However, the monomeric 
form present in cells with depolarized mitochondrial membranes 
emits only green fluorescence. We found MMP to be decreased 
teristics of senescence, yet had potent functional activity, includ-
ing cytotoxic activity and secretion of TNF-α and IFN-γ after acti-
vation. However, these cells had very low proliferative activity. In 
contrast, the effector memory (EM) CD8+ T cell population was 
also functionally potent, but also highly proliferative compared 
with the senescent CD8+ T cells. We found that while EM CD8+ 
T cells used OXPHOS in conjunction with glycolysis to generate 
energy, the senescent EMRA CD8+ T cells used anaerobic glycoly-
sis preferentially. Senescent CD8+ T cells produced more ROS and 
exhibited mitochondrial dysfunction, which may explain their 
dependence on glycolysis for energy. A key observation was that 
p38 signaling in these cells increased mitochondrial biogenesis as 
well as telomerase and proliferative activity after activation. The 
senescent CD8+ T cells also retained most of their effector func-
tions after p38 blockade, which suggests that these cells require 
more energy than unblocked cells. We found that despite their 
reversal of mitochondrial defects, these cells still preferentially 
engaged anaerobic glycolysis after p38 inhibition. Furthermore, 
the additional energy required for proliferation was obtained from 
autophagy, via an mTOR-independent pathway. We therefore 
concluded that the extra energy required for the reconstituted pro-
liferative activity in senescent CD8+ T cells after p38 blockade is 
generated by the recycling of intracellular macromolecules.
Results
EMRA CD8+ T cells exhibit phenotypic, functional, and DNA dam-
age response parameters characteristic of senescence. Human CD8+ 
T cells can be subdivided into 4 populations on the basis of their 
relative surface expression of CD45RA and CD27 molecules (Sup-
plemental Figure 1A; supplemental material available online with 
this article; doi:10.1172/JCI75051DS1). These subsets — naive 
(CD45RA+CD27+), central memory (CM; CD45RA–CD27+), EM 
(CD45RA–CD27–), and EMRA (CD45RA+CD27–) — are analogous 
to those identified in other reports in which surface CCR7 together 
with CD45RA expression were used to distinguish among T cells 
at different stages of differentiation (17). In previous studies, based 
on cell surface phenotype alone, the EMRA subset has been postu-
lated to represent a senescent population of cells that accumulated 
with age and certain diseases (18). In the present study, EMRA 
CD8+ T cells were found to constitute between 4% and 42% of the 
CD8+ compartment (median, 22%). The first aim of this study was 
to provide an unequivocal definition of a senescent human CD8+ 
T cell population by investigating multiple phenotypic and func-
tional parameters of senescence.
We investigated the surface coexpression of KLRG1 and CD57, 
which have been proposed to identify senescent T cells (7, 9), as 
well as phosphorylated H2AX (γH2AX), a member of the histone 
H2A family that is part of the DNA damage response (DDR) in 
senescent cells (19) isolated from young individuals. Although 
senescent cells accumulate during aging (20), some are also found 
in young subjects as a result of antigenic stimulation (21). We 
found that after stimulation, the EMRA CD8+ T cells expressed the 
greatest number of senescence markers simultaneously (Figure 
1A). However, not all EMRA CD8+ T cells were senescent; 30% of 
this population displayed no markers of senescence. In addition, 
it has previously been shown that memory T cells have signifi-
cantly shorter telomeres than the naive population (13, 22), which 
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(25). We next investigated whether decreased mitochondrial func-
tion in EMRA CD8+ T cells is associated with differences in their 
metabolism compared with the other memory subsets. We first 
investigated whether there were differences in the way that CD8+ 
T cell subsets were able to use exogenous glucose, by assessing 
their expression of the glucose transporter Glut1 (26). EMRA CD8+ 
T cells showed the lowest expression of this transporter molecule 
(Figure 3, A and B), which suggests that this subset may not be able 
to access extracellular glucose as effectively as the other subsets.
in EMRA CD8+ T cells (Figure 2, F and G), indicative of the pres-
ence of dysfunctional depolarized mitochondria. Together, these 
data showed that EMRA CD8+ T cells have lower mitochondrial 
content than other memory subsets and that what mitochondria 
remain are more dysfunctional.
EMRA CD8+ T cells undergo anaerobic glycolysis. Decreased 
mito chondrial function in aged liver and muscle cells has been 
shown to result in a decline in energy production, causing metabol-
ic reprogramming toward extramitochondrial energy production 
Figure 1. EMRA CD8+ T cells exhibit characteristics of senescent T cells. (A) Multiparameter flow cytometry examining expression of the senescence 
features KLRG1, CD57, and γH2AX in the 4 CD45RA/CD27-defined CD8+ T cell subsets after an 8-hour stimulation with 0.5 μg/ml anti-CD3. Pie charts show 
the average of 7 donors. N, naive. (B) Representative blot showing telomerase activity on day 3 after activation with 0.5 μg/ml anti-CD3 and 5 ng/ml IL-2 
(n = 4). Lanes were run on the same gel but were noncontiguous (black line). Telomerase activity was calculated by densitometry and expressed in arbitrary 
units relative to the internal standard (IS). (C) Representative immunoblots of p-p38 and total p38 together with β-actin after a 30-minute stimulation 
with 0.5 μg/ml anti-CD3 and 5 ng/ml IL-2. (D) Phosphoflow data after a 30-minute stimulation with 0.5 μg/ml PMA and ionomycin. Data are shown rela-
tive to the naive subset, n = 9. (E and F) ROS production, obtained using MitoSox (E) and DHE (F), in the CD8+ T cell subsets after overnight stimulation  
(n = 8). (G) Proliferation of CD8+ T cell subsets, assessed by Ki67 staining, after stimulation with 0.5 μg/ml anti-CD3 and 5 ng/ml IL-2 for 3 days. Horizontal 
lines depict means. (H) Multiparameter flow cytometry examining expression of IFN-γ, TNF-α, perforin, and granzyme B after an 8-hour stimulation with 
0.5 μg/ml anti-CD3. Pie charts show the average of 7 donors. *P < 0.05, **P < 0.01, ***P < 0.001, repeated-measures ANOVA followed by Tukey correction.
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The key features of note in this mitochondrial stress test were 
the higher basal metabolic rate and oxygen consumption rate 
(OCR), together with greater SRC, in the CM and EM subsets 
compared with the naive and EMRA populations (Figure 3C). 
This increased OCR was an indicator of CM and EM CD8+ T cells 
undergoing OXPHOS. However, the extracellular acidification 
rate (ECAR), a marker of lactic acid production and glycolysis, 
was higher in EM and EMRA CD8+ T cells than the naive and CM 
subsets (Figure 3D). This suggests that naive T cells have low abil-
ity to perform OXPHOS and glycolysis and are highly dependent 
on exogenous glucose to generate energy. Moreover, CM CD8+ 
T cells mainly utilize OXPHOS, whereas the EMRA population 
mainly utilizes glycolysis, and the EM subset exhibits the great-
est metabolic versatility, able to engage either OXPHOS or gly-
colysis after TCR activation. The EM and EMRA subsets were also 
found to have the lowest OCR/ECAR ratios (Figure 3E), further 
strengthening the idea that these cells undergo glycolysis.
SRC, the mitochondrial capacity available to cells in order to 
produce energy under conditions of increased effort or stress, is 
We next measured the bioenergetic profiles of stimulated 
CD45RA/CD27-defined CD8+ T cell subsets after a mitochondrial 
stress test (Figure 3C), which includes the addition of pharmaco-
logical inhibitors of OXPHOS. 3 different compounds are added in 
succession, altering the bioenergetic profile of the T cells (27). The 
first compound is oligomycin, an ATP coupler that inhibits ATP 
synthesis by blocking complex V and is used to distinguish the per-
centage of oxygen consumption dedicated to ATP synthesis and to 
overcome the natural proton leak across the inner mitochondrial 
membrane. The second is FCCP, which uncouples ATP synthesis 
from the electron transport chain by transporting H+ ions across 
the inner mitochondrial membrane. The collapse of the MMP 
leads to the consumption of both oxygen and energy without gen-
erating ATP and is used to calculate the spare respiratory capacity 
(SRC). The third is a mixture of rotenone and antimycin A, which 
blocks complexes I and III, respectively, of the electron transport 
chain, shutting down mitochondrial respiration and thereby allow-
ing for calculation of both the mitochondrial and nonmitochondri-
al fractions contributing to respiration (Supplemental Figure 2D).
Figure 2. EMRA CD8+ T cells display mitochondrial impairment after stimulation. CD45RA/CD27-defined CD8+ T cells were stimulated overnight with  
0.5 μg/ml anti-CD3 and 5 ng/ml IL-2. (A) Electron microscope images. Arrows denote mitochondria. Scale bars: 1 μM. (B) Percentage by cell volume of 
mitochondria, determined by a point counting grid method from 10 different electron microscope images. (C and D) Representative examples (C) and data 
(D) showing the expression of Mitotracker Green (n = 8). (E) mtDNA/nDNA ratio (n = 4). (F and G) Representative example (F) and data (G) showing JC-1 
staining (n = 5). The percentage of cells expressing JC-1 red and/or JC-1 green is indicated within the respective quadrants. *P < 0.05, **P < 0.01,  
***P < 0.001, repeated-measures ANOVA followed by Tukey correction.
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Naive, CM, EM, and EMRA CD8+ T cells were next stimu-
lated in the presence of BIRB 796 or DMSO control for 3 days, 
and the effect on mitochondrial mass was investigated. Only 
the EMRA subset responded to treatment with BIRB 796 (Sup-
plemental Figure 2E). After activation of these cells for 3 days, 
giant mitochondria lacking cristae were observed in the EMRA 
population (Figure 5A). Electron microscope images showed 
that after p38 MAPK blockade, the mitochondrial architecture 
was restored, and the giant mitochondria were no longer pres-
ent (Figure 5A). Furthermore, the EMRA CD8+ T cells incu-
bated with BIRB 796 contained significantly more mitochon-
dria per unit volume of cytoplasm, which was confirmed by 
measurement of mitochondrial mass using MitoTracker green 
(Figure 5, B–D). We then investigated whether the increased 
mitochondrial mass caused by BIRB 796 was associated with 
improved function; after stimulation in the presence of BIRB 
796, MMP (JC-1 red/JC-1 green ratio) increased significantly 
in EMRA CD8+ T cells (Figure 5, E and F). Therefore, inhibi-
tion of p38 signaling in EMRA CD8+ T cells caused an increase 
in the number of mitochondria, which were also more func-
tional. This raises the question of whether this leads to an 
increase in OXPHOS to support the extra energy required for 
enhanced proliferative activity in the EMRA population.
We addressed this by performing a mitochondrial stress 
test on EMRA CD8+ T cells after 3 days of stimulation in the pres-
ence of BIRB 796. The bioenergetic profile revealed no change in 
OCR between EMRA CD8+ T cells incubated with or without BIRB 
796 (Figure 6A). ECAR revealed that EMRA CD8+ T cells incubat-
ed with BIRB 796 produced more lactic acid (Figure 6B), indicative 
of increased glycolysis. Taken together with the observed drop in 
OCR/ECAR ratio (Figure 6C), these results suggest that, despite 
the enhanced mitochondrial function after p38 MAPK inhibition, 
EMRA CD8+ T cells still engage glycolysis to provide the energy 
required for the increase in proliferation after activation.
Increased energy demand with p38 inhibition is met by increased 
autophagy via an mTORC1-independent mechanism. Although 
EMRA CD8+ T cells are dependent on glycolysis, they may not be 
able to increase their metabolic needs by increasing their uptake 
of extracellular glucose, since these cells expressed relatively low 
levels of the glucose transporter Glut1 (Figure 3, A and B), which 
was not changed after treatment with BIRB 796 (Figure 6D). This 
raised the question of how these cells fuel the increase in glycolysis. 
One possible nutrient source when extracellular nutrient uptake is 
insufficient to meet cellular energy demands is macroautophagy 
(autophagy). We therefore used an imaging flow cytometry–based 
assay (ImageStream) to assess autophagy in all 4 CD8+ T cell sub-
important for long-term survival and function (28). Collectively, 
the lower SRC in EMRA CD8+ T cells together with lower mitochon-
drial mass (Figure 2, A–E), increased ROS production (Figure 1, 
E and F), and decreased MMP (Figure 2, F and G) suggests that 
these cells are very metabolically unstable compared with the oth-
er memory subsets, yet are still able to generate sufficient energy 
for effector functions (Figure 1G).
p38 MAPK inhibition partially restores mitochondrial function in 
EMRA CD8+ T cells. Previous studies in CD4+ T cells have shown 
that the decreased proliferation and telomerase activity in the high-
ly differentiated EMRA subset can be partially restored by blocking 
p38 MAPK activity with the specific small-molecule inhibitor BIRB 
796 (13). When used at a concentration of 500 nM, BIRB 796 spe-
cifically inhibits p38 MAPK (13). We therefore investigated whether 
blocking p38 in EMRA CD8+ T cells had the same effect. Addition 
of BIRB 796 to EMRA CD8+ T cells enhanced both their prolifera-
tion and their telomerase activity after activation (Figure 4, A–D). 
Inhibition of p38 signaling significantly reduced TNF-α, but not 
granzyme B, perforin, or IFN-γ, by EMRA CD8+ T cells, as mea-
sured by flow cytometry (Figure 4E). This raised the question of 
whether p38 inhibition would affect mitochondrial function and/or 
metabolic pathways for energy production in these cells.
Figure 3. EMRA CD8+ T cells undergo anaerobic glycolysis. (A and B) 
Examples (A) and data (B) showing Glut1 expression within CD45RA/
CD27-defined CD8+ T cell subsets after overnight stimulation with 0.5 
μg/ml anti-CD3 (n = 8). (C) OCR of CD8+ T cell subsets were measured 
after overnight stimulation with 0.5 μg/ml anti-CD3 and 5 ng/ml IL-2, 
and cells were then subjected to a metabolic stress test using the indi-
cated mitochondrial inhibitors. Data are representative of 4 indepen-
dent experiments. (D and E) Basal ECAR (D) and basal OCR/ECAR ratio 
(E) of the CD8+ T cell subsets after overnight stimulation with 0.5 μg/
ml anti-CD3 and 5 ng/ml IL-2 (n = 4). *P < 0.05, **P < 0.01, ***P < 0.001, 
repeated-measures ANOVA followed by Tukey correction.
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sets (Figure 6E). Relocalization of LC3 puncta to autophagosomal 
membranes and increased lysosomal content are both hallmarks 
of autophagy (29). Detection of autophagy should measure both of 
these as well as delivery of LC3 to the lysosomes (reflected by the 
colocalization of LC3 and lysosomal markers). The fluorescence 
intensity of both endogenous LC3 and the lysosomal marker Lyso-
ID, along with their colocalization index (bright detail similarity; 
BDS), can be detected using ImageStream technology, as previ-
ously described by Phadwal and colleagues (29). Using this meth-
od, we found that after a 2-hour stimulation, EMRA CD8+ T cells 
displayed low levels of autophagy, as shown by the BDShi percent-
age among double-positive cells (Figure 6, E and G). However, 
when stimulated in the presence of BIRB 796, these cells showed 
the highest increase in autophagic activity (Figure 6, F and G).
We next investigated how the increase in autophagic activity 
was regulated. The inhibitory activity of mTORC1 on autophagy 
has been well documented, and its activity reflects cellular nutri-
tional status (30). We found that expression of phosphorylated 
S6 (pS6; a downstream effector of mTORC1) decreased progres-
sively, from naive to CM to EM, with the EMRA subset expressing 
very little pS6 ribosomal protein after stimulation (Figure 7, A and 
B). This result was not simply a difference in the kinetics of pS6 in 
the EMRA subset: over the course of a 12-hour period, the level of 
pS6 did not change (Supplemental Figure 3A), pointing to a lack 
of involvement of mTORC1 in regulating autophagy in these cells. 
These findings were confirmed using ImageStream technology, 
after a 2-hour stimulation with or without the mTORC1 inhibitor 
rapamycin (Figure 7C). EMRA CD8+ T cells were the only subset 
that did not display an increase in autophagic activity in the pres-
ence of rapamycin, as demonstrated by the unchanged BDShi ratio 
among LC3 and Lyso-ID double-positive cells (Figure 7D). Fur-
ther verification that mTORC1 was not involved in EMRA CD8+ 
T cells came from the inclusion of BIRB 796, where EMRA CD8+ 
T cells showed no change in pS6 (Supplemental Figure 3, B and 
C), and from siRNA-mediated knockdown of MK2. The knock-
down of this downstream kinase of p38 MAPK, which enhances 
mTORC1 (31), was found to decrease pS6 in naive, CM, and EM 
CD8+ T cells, but not the EMRA population (Supplemental Figure 
3, D–F). Thus, autophagy is not regulated by mTORC1 signaling 
in EMRA CD8+ T cells.
Our findings strongly suggest that p38 MAPK inhibits 
autophagy and that blocking this kinase enables the use of the 
degraded cellular proteins and organelles, in order to provide 
EMRA CD8+ T cells with an additional energy source via an 
mTORC1-independent mechanism.
p38 MAPK controls autophagy in EMRA CD8+ T cells by regu-
lating the p38IP-ATG9 interaction. To further understand how 
p38 MAPK regulates autophagy, we investigated the role of p38 
interacting protein (p38IP), a protein that binds both p-p38 MAPK 
and autophagy protein 9 (ATG9), a key transmembrane protein 
required for trafficking during autophagy (32). ATG9 has been 
shown to localize to the trans-Golgi network (TGN) and late endo-
somes, where it enables autophagy, with p38IP regulating this traf-
ficking (33). P-p38 can inhibit the trafficking of ATG9, as it has a 
higher binding affinity for p38IP than ATG9. We therefore investi-
gated whether p38 MAPK regulates autophagy in the EMRA sub-
set by preventing the interaction between ATG9 and p38IP. Using 
ImageStream, we found that after a 2-hour stimulation in the 
presence of BIRB 796, the amount of ATG9 colocalized with TGN 
markedly decreased, whereas colocalization of ATG9 with late 
Figure 4. Signaling through p38 MAPK pathways contribute 
to reduced proliferation and telomerase activity of EMRA 
CD8+ T cells. (A) Representative example of Ki67 staining 
on EMRA CD8+ T cells measured after 3 days of stimulation 
with 0.5 μg/ml anti-CD3 and 5 ng/ml IL-2 in the presence or 
absence of 500 nM BIRB 796. Numbers depict percent Ki67+ 
cells. (B) Effect of BIRB 796 on proliferation of EMRA CD8+ T 
cells activated as in A (n = 5). (C and D) Representative blot 
(C) and data (D) showing telomerase activity in EMRA CD8+ 
T cells on day 3 after activation as in A (n = 4). (E) Expression 
of IFN-γ, TNF-α, granzyme, and perforin in EMRA CD8+ T 
cells after an 8-hour stimulation with 0.5 μg/ml anti-CD3 (n 
= 5). *P < 0.05, paired t test.
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endosomes increased, thus facilitating autophagy (Figure 8, A–D). 
While LAMP1 also marks lysosomes and autolysosomes, we dem-
onstrated here that inhibition of p38 MAPK signaling alters the 
trafficking of ATG9. The effect of BIRB 796 on ATG9 trafficking 
was only observed in the EMRA subset (Figure 8, E and F), which 
suggests that p38 MAPK negatively regulates the p38IP-ATG9 
interaction and prevents redistribution of ATG9 to the endosomes 
controlling the level of autophagy.
Discussion
The paradigm of cellular senescence has mainly been defined in 
stromal cells such as fibroblasts that grow in vitro (19, 34). Although 
senescence-like characteristics have also been described in prima-
ry human T lymphocytes, this has largely been based on analysis 
of whole-lymphocyte fractions (35, 36). Furthermore, while many 
publications have investigated either the cell signal-
ing processes or the functional activity of the senescent 
subpopulation, the majority of these have used loss of 
CD28 expression as a marker of senescence (10, 11). We 
previously found that while EMRA CD8+ T cells are all 
CD28–, the majority of EM CD8+ T cells, which do not 
exhibit functional characteristics of senescence, are also 
CD28– (20). In order to obtain a more complete defini-
tion of primary human T cell senescence, we performed 
an extensive phenotypic and functional analysis of the 
senescence characteristics of freshly isolated human 
CD8+ T cells that were identified at different stages of 
differentiation by their relative expression of CD45RA 
and CD27. After T cell activation, the EMRA CD8+ T 
cell population (CD45RA+CD27–) had reduced prolifera-
tive capacity, together with low telomerase expression, 
extensive expression of DNA damage foci, and activation 
of the key senescence-signaling molecule p38 MAPK, all 
of which were indicative of senescence rather than qui-
escence. Furthermore, the loss of mTOR in EMRA CD8+ 
T cells was also indicative of senescence, as mTOR activ-
ity has been shown to enforce quiescence (37). These 
cells also expressed high levels of CD57 and KLRG1 
and low levels of CD28, considered to be a characteris-
tic of senescent T cells (7, 9). However, EM CD8+ T cells 
(CD45RA–CD27–) also expressed high levels of CD57 and 
KLRG1 and low levels of CD28, like the EMRA popula-
tion, but could proliferate and express telomerase activ-
ity after activation, which indicates that they are not a 
senescent population. Although loss of CD28 expression 
is a feature of exhausted human CD8+ T cells (38), EMRA CD8+ T 
cells were not functionally exhausted, as they retained cytotoxic 
capability and produced high levels of IFN-γ and TNF-α; further-
more, they only expressed low levels of key markers of exhaus-
tion, such as PD-1 (39, 40). Additionally, EMRA CD8+ T cells had 
a lower turnover than effectors; however, the rate of death/disap-
pearance of this subset was decreased, implying that it represents 
a long-lived pool of cells that persist in the circulation (41).
The senescent characteristics of EMRA CD8+ T cells may not 
be induced by telomere erosion alone (42). Although these cells 
have shorter telomeres than naive CD8+ T cells, they have sig-
nificantly longer telomeres than the EM subpopulation. Senes-
cence can also be induced by damage by ROS (1). We found that 
EMRA CD8+ T cells expressed high levels of both mitochondrial 
and cytoplasmic ROS, exhibited large dysfunctional mitochondria 
Figure 5. Inhibiting p38 MAPK pathways reverses mitochon-
drial dysfunction in EMRA CD8+ T cells. EMRA CD8+ T cells were 
stimulated for 3 days with 0.5 μg/ml anti-CD3 and 5 ng/ml IL-2 
plus either 0.1% DMSO or 500 nM BIRB 796. (A) Electron micro-
scope images. Scale bars: 2 μM (top); 1 μM (bottom left); 0.5 μM 
(bottom right). (B) Percentage by cell volume of mitochondria, 
determined by a point counting grid method from 50 different 
electron microscope images. (C and D) Representative example 
(C) and data (D) showing expression of Mitotracker Green (n = 5). 
(E and F) Example (E) and data (F) showing JC-1 staining (n = 5). 
*P < 0.05, paired t test.
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energetic advantage, whereas in senescent cells, mitochondrial 
content was markedly reduced and the mitochondrial membrane 
hyperpolarized, leading to increased ROS production.
Previous studies have shown that EMRA CD8+ T cells preferen-
tially localize to peripheral organs, where they may have to perform 
their effector functions under hypoxic conditions (45), suggestive 
of a link among metabolism, migration, and effector function (46). 
Our present results extended this concept by showing that highly 
functional senescent CD8+ T cells that have the typical glycolytic 
pathway dependence of cytotoxic effector cells may represent a 
senescent population. This raises the possibility that senescence 
signaling, cellular metabolism and effector function are regulat-
ed in tandem in these cells. EMRA CD8+ T cells had very potent 
effector function despite their mitochondrial dysfunction, raising 
the question of whether the energy required for proliferation is 
sacrificed to ensure that cytotoxic activity and cytokine secretion 
can take place. EM CD8+ T cells, which also have potent cytotoxic 
potential and secrete cytokines, can also proliferate; however, in 
contrast to the senescent EMRA population, these cells can utilize 
both OXPHOS and aerobic glycolysis. This extends the emerging 
with little or no cristae, and had a lower MMP. This is in line with 
studies reporting that aging cells show accumulation of giant or 
highly interconnected mitochondria, characterized by loss of cris-
tae structure and swollen morphology (43).
Decreased mitochondrial function in aged liver and muscle 
cells has been shown to result in a decline in energy production, 
causing metabolic reprogramming toward extramitochondrial 
energy production (25). We showed here that senescent CD8+ 
T cells also adopted anaerobic glycolysis instead of OXPHOS to 
produce energy. Mitochondrial dysfunction may also be a reason 
why highly functional effector cells use glycolysis despite being 
less efficient than OXPHOS at generating energy, a feature that 
has also been reported in murine effector T cells (44). In mice, 
these metabolic changes in effector cells are regulated through the 
induction of mitochondrial biogenesis and an increased capacity 
to respond to metabolic stress, a characteristic quantified as SRC 
(28). We found the SRC to be high in early differentiated human 
memory CD8+ T cells, but substantially decreased in senescent 
CD8+ T cells. This correlated with the changes in mitochondrial 
mass: it was higher in the CM and EM subsets, conferring a bio-
Figure 6. Blocking the p38 MAPK pathway does not lead to metabolic remodeling. 
(A–D) EMRA CD8+ T cells were stimulated for 3 days with 0.5 μg/ml anti-CD3 and 5 
ng/ml IL-2 plus 0.1% DMSO or 500 nM BIRB 796. (A–C) Basal OCR (A), basal ECAR (B), 
and basal OCR/ECAR ratio (C) (n = 3). (D) Glut1 expression (n = 5). (E–G) EMRA CD8+ T 
cells were stimulated for 2 hours with 0.5 μg/ml anti-CD3 and 5 ng/ml IL-2 plus either 
0.1% DMSO or 500 nM BIRB 796. (E and F) ImageStream images showing autophagy 
levels without (E) and with (F) BIRB 796. 4 representative images for each condition 
are shown: brightfield (BF), LC3 (green), Lyso-ID (red), and a merge of LC3 and Lyso-ID. 
Original magnification, ×60. (G) Colocalization index (BDS) of endogenous LC3 and 
Lyso-ID (n = 4). *P < 0.05, **P < 0.01, paired t test.
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switched their metabolism to OXPHOS to supply the extra energy 
demands for cell cycling. Instead, we found that these cells still 
preferentially engaged glycolysis; however, this was not associated 
with an increased uptake of glucose, as expression of the glucose 
transporter Glut1 remained unchanged in the senescent CD8+ T 
cells both with and without addition of BIRB 796 during activation.
Autophagy can generate metabolic precursors from lysosomal 
digestion of organelles and other materials for metabolism (47). 
Furthermore, mouse models have shown that autophagy supports 
glycolysis and that autophagy competence is required for cells to 
proliferate and expand (48). We found that senescent CD8+ T cells 
data from mouse models showing that effector CD8+ T cells main-
tain OXPHOS in conjunction with glycolysis (28).
In a previous study, it was shown that p38 blockade could 
increase the proliferation and telomerase activity of highly differ-
entiated CD4+ T cells (13). We therefore investigated whether inhi-
bition of p38 MAPK, expression of which was elevated in senescent 
CD8+ T cells, could increase proliferation and alter the metabo-
lism of the cell after activation. We showed here that blocking p38 
MAPK caused an increase in mitochondrial mass and improved 
mitochondrial function, which translated to an enhanced prolifera-
tive capacity. This raised the question of whether these cells now 
Figure 7. Increased autophagic activ-
ity in EMRA CD8+ T cells is achieved 
via an mTORC1-independent 
mechanism. (A and B) Example (A) 
and data (B) of pS6 within the CD8+ 
T cell subsets following a 2-hour 
stimulation with 0.5 μg/ml anti-CD3 
(n = 5). (C and D) CD8+ T cell subsets 
were stimulated for 2 hours with 
0.5 μg/ml anti-CD3 and 5 ng/ml IL-2 
plus either 0.1% DMSO or 100 nM 
rapamycin. (C) ImageStream images 
showing autophagy levels. 4 repre-
sentative images for each condition 
are shown: brightfield, LC3 (green), 
Lyso-ID (red), and a merge of LC3 
and Lyso-ID. Original magnification, 
×60. (D) Colocalization index (BDS) of 
endogenous LC3 and Lyso-ID (n = 4). 
*P < 0.05, **P < 0.01, ***P < 0.001, 
repeated-measures ANOVA followed 
by Tukey correction.
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blockade in EMRA CD8+ T cells induced a considerable increase in 
autophagy, allowing for the increased biosynthesis in these cells.
We found that p38 MAPK inhibited autophagy in an mTOR-
independent manner. The observed reduction in phosphoryla-
tion of the S6 ribosomal protein, a surrogate marker for mTORC1 
displayed low autophagic activity, in line with a previous report 
investigating CD8+CD28–CD57+ T cells (29). The absence of key 
autophagy genes has been shown to increase both ROS and dam-
age to the lymphoid mitochondria (49), linking mitochondrial 
oxidative stress with autophagy (29). A key finding was that p38 
Figure 8. p38 MAPK controls autophagy in EMRA CD8+ T cells by regulating the p38IP-ATG9 interaction. EMRA CD8+ T cells were stimulated for 2 hours 
with 0.5 μg/ml anti-CD3 and 5 ng/ml IL-2 plus either 0.1% DMSO or 500 nM BIRB 796. (A) ImageStream images showing colocalization of ATG9 with 
TGN46. 4 representative images per condition are shown: brightfield, TGN46 (green), ATG9 (red), and a merge of TGN46 and ATG9. (B) Colocalization of 
ATG9 with LAMP1. 4 representative images per condition are shown: brightfield, ATG9 (red), LAMP1 (blue), and a merge of ATG9 and LAMP1. Original mag-
nification, ×60 (A and B). (C and D) Representative BDS overlay histogram of EMRA CD8+ T showing colocalization of TGN46 and ATG9 (C) and of LAMP1 
and ATG9 (D). Colocalization index (BDS) of TGN46 and ATG9 (E) and of LAMP1 and ATG9 (F) (n = 4). *P < 0.05, **P < 0.01, repeated-measures ANOVA 
followed by Tukey correction.
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stain (Invitrogen), KLRG1 PE (13F12; gift from H. Pircher, University 
of Freiburg, Freiburg, Germany), CD45RA Brilliant Violet 605 (Biole-
gend), Via Probe, CD8 PerCP (SK1), CD8 Alexa Fluor 700 (RPA-T8), 
CD27 FITC (M-T271), CD27 APC-H7 (M-T271), CD45RA PE-Cy7 
(L48), and CD57 APC (NK-1). For intracellular staining, the follow-
ing antibodies were used (all from BD Biosciences, unless other-
wise specified): pS6 ribosomal protein (Ser235/236, D457.2.2E; Cell 
Signaling), IFN-γ V450 (B27), granzyme B Alexa Fluor 700 (GB11), 
TNF-α PE (MAb11), perforin FITC (ΔG9), and p-p38 Alexa Fluor 488 
(36/p38). Intranuclear staining was performed using γH2AX Alexa 
Fluor 488 (2F3; Biolegend) and Ki67 FITC (B56; BD Biosicences). 
All samples were run using an LSR II (BD Biosciences) and analyzed 
using FlowJo software (Treestar).
CD8+ T cells were purified by positive selection using the VARI-
OMACS system (MiltenyiBiotec) according to the manufacturer’s 
instructions. Positively selected CD8+ T cells were labeled with 
CD27 FITC (M-T271; BD Biosciences) and CD45RA APC (HI100; 
BD Biosciences) and sorted using a FACSAria (BD Biosciences). The 
purity of CD8+ T cell subsets was assessed by flow cytometry. Mul-
tiparamter flow cytometry was analyzed, and presentation of distri-
butions was performed using SPICE version 5.2 (http://exon.niaid.
nih.gov/spice/; ref. 59).
Phosphoflow cytometry. Analysis of p-p38 (pT180/pY182) was per-
formed after a 30-minute stimulation with 0.5 μg/ml PMA/ionomy-
cin. Following surface staining for CD45RA, CD27, and CD8, PBMCs 
were fixed with warm Cytofix Buffer (BD Biosciences). Cells were then 
permeabilized with ice-cold Perm Buffer III (BD Biosciences) and 
incubated with the anti-p38 antibody (pT180/pY182) for 30 minutes 
at room temperature. For the detection of γH2AX (pS139), purified 
subsets were activated with 0.5 μg/ml plate coated anti-CD3 (OKT3) 
and 5 ng/ml of rhIL-2 (Peprotech) overnight, pS6 ribosomal protein 
(Ser235/236, D57.2.2E, Cell Signaling) was measured following a 
2-hour stimulation with 0.5 μg/ml plate coated anti-CD3 (OKT3), after 
which the above staining method was used.
Western blot analysis. Cell lysates were made from sorted 
CD45RA/CD27 CD8+ T cell subsets by sonication in 50 mM Tris-HCl 
(pH 7.5), 2 mM EGTA, and 0.1% Triton X-100 buffer. Lysates from 
1 × 106 cells were fractionated by SDS–polyacrylamide electrophoresis 
and analyzed by immunoblotting with p-p38 MAPK (12F8; Cell Sig-
nalling), using the ECL Advanced Western Blotting Detection Kit (GE 
Healthcare) according to the protocol provided by the manufacturer.
Proliferation assays. CD45RA/CD27-sorted CD8+ T cells were 
stimulated with 0.5 μg/ml plate coated anti-CD3 (OKT3) and 5 ng/ml 
IL-2 for 3 days, and proliferation was assessed by staining for the cell 
cycle–related nuclear antigen Ki67 as described previously (8).
Mitochondrial measurements. For all mitochondrial experiments, 
freshly isolated PBMCs were first surface stained using Via Probe, CD8 
Alexa Fluor 700, CD27 APC (BD Biosciences), and CD45RA Brilliant 
Violet 605 (Biolegend). For assessment of mitochondrial mass, the 
labeled PBMCs were incubated with 100 nM MitoTracker Green FM 
(Invitrogen) for 30 minutes at 37°C, 5% CO2. MMP was investigated 
using JC-1 (Invitrogen); 2 μM JC-1 was incubated with labeled PBMCs 
for 30 minutes at 37°C, 5% CO2. Addition of 100 μM CCCP was used to 
confirm that the JC-1 response was sensitive to changes in MMP. Unfixed 
samples were immediately collected on a LSR II (BD Bioscience).
Relative quantification of mtDNA copy number was performed 
by extracting genomic DNA using the QIAamp DNA kit (Qiagen). The 
activation, declined during differentiation from the naive to the 
EMRA subset. This is in line with reports that the transition to a 
memory phenotype is associated with a metabolic switch from 
anabolism to catabolism (46, 50) via inhibition of mTOR (51). We 
have also previously shown that highly differentiated CD8+ T cells 
lack the ability to phosphorylate Akt (21), an upstream activator 
of mTORC1, which suggests that the PI3K/Akt/mTOR pathway 
does not play a role in senescent T cells. We postulate here that 
autophagy is regulated in EMRA CD8+ T cells via p38 MAPK inde-
pendently of mTOR, in part by the preferential binding of p-p38 
MAPK to p38IP compared with that of ATG9 to p38IP, thereby reg-
ulating the trafficking and function of ATG9. It is now becoming 
apparent that there are a variety of noncanonical pathways leading 
to autophagosomal degradation through variants of the canoni-
cal pathway (52). Indeed, the existence of noncanonical forms of 
autophagy that can bypass the AMPK-mTOR-ULK1 circuit of ini-
tiation have been documented (53). Furthermore, Beclin 1–inde-
pendent autophagy was observed where ROS and/or mitochon-
drial damage are involved (54), with ATG9 being independently 
recruited to depolarized mitochondria (55). Here, we described 
a novel subset-specific noncanonical mechanism whereby p-p38 
MAPK negatively regulates autophagy in the EMRA CD8+ T cells.
Collectively, our results suggest that some aspects of senes-
cence in human CD8+ T cells are mediated by p38 MAPK signal-
ing and are reversible. We postulate that inhibition of p38 MAPK 
increases autophagy, releasing metabolic precursors and allowing 
the cell to increase its proliferative capacity. Proliferation was only 
increased in the EMRA subset, either directly or indirectly through 
the removal of p53, as p38 plays a key role in its phosphorylation 
and activation (3). Senescent T cells closely resembled the clas-
sically defined short-lived effector T cells that arise during an 
immune response; however, EM CD8+ T cells also had effector 
function, but were not senescent. Both these populations of effec-
tor cells were very different metabolically and used different path-
ways to generate energy, which were not governed by p38 MAPK 
signaling. This reversibility of the senescent CD8+ phenotype is 
important, as the number of EMRA CD8+ T cells increases con-
siderably during aging (20) as well as in patients with autoimmune 
diseases (56), malignancy (57), and persistent infections (58). 
Finally, it remains unanswered whether reestablishment of pro-
liferative activity in senescent CD8+ T cells by p38 blockade may 
improve immune responsiveness in these subjects.
Methods
Blood sample collection and isolation. Heparinized peripheral blood 
samples were taken from young, healthy volunteers (age range, 
20–35 years; median, 31 years; n = 62). Healthy was taken as indi-
viduals who had not had an infection or immunization within the last 
month, had no known immunodeficiency or any history of chemo-
therapy or radiotherapy, and were not receiving systemic steroids 
within the last month or any other immunosuppressive medications 
within the last 6 months. PBMCs were isolated using Ficoll hypaque 
(Amersham Biosciences) and either analyzed immediately or cryo-
preserved as described previously (8).
Flow cytometric analysis and cell sorting. Flow cytometric analysis 
was performed using the following antibodies (all from BD Biosci-
ences, unless otherwise specified): live/dead fixable blue dead cell 
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CD8, CD45RA, and CD27; fixed and permeabilized using eBioscience 
Fixation and Permeabilization kit; stained with polyclonal LC3 (MBL); 
and run on ImageStream. Autophagy levels were calculated by measur-
ing percent colocalization of LC3hiLysohi CD45RA/CD27-defined CD8+ 
T cell subsets, achieved by measuring the BDS between LC3 and lyso-
somal markers normalized against the frequency of cells (29).
Colocalization of ATG9 and the TGN and endosomes. Colocalization 
was investigated using ImageStream. PBMCs were incubated with or 
without BIRB 796 and the inhibitors E64d and pepstatin A (Sigma-
Aldrich; 10 μg/ml each) to induce autophagy for 2 hours. Subsequent-
ly, PBMCs were surface stained with CD8, CD45RA, and CD27; fixed 
and permeabilized using eBioscience Fixation and Permeabilization 
kit; stained with ATG9 (generated as described previously; ref. 60), 
TGN46 (AHP500G; AbD Serotec), and CD107a (1D4B; BD Bioscienc-
es); and run on ImageStream. Colocalization was calculated by mea-
suring percent BDS of ATG9hiTGN46hi or ATG9hiLAMP1hi CD45RA/
CD27-defined CD8+ T cell subsets, followed by determining the ratio 
of BDS in the presence and absence of the autophagy inhibitors.
Statistics. Graphpad Prism was used to perform statistical analysis. 
Statistical significance was evaluated using 2-tailed paired Student’s t 
test or repeated-measures ANOVA with Tukey correction for post-hoc 
testing. Bar graphs show mean ± SEM. A P value less than 0.05 was 
considered significant.
Study approval. The present study was reviewed and approved by 
the ethical committee of Royal Free and University College Medical 
School. All subjects provided written informed consent.
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resulting DNA was used to determine mtDNA/nDNA ratios by real-
time PCR using primers against NADH dehydrogenase I and beta-2 
microglobulin using the Applied Biosystems 7500 sequence detection 
system. The expression of mtDNA for genes of interest was normal-
ized to the expression of the housekeeping gene (B2M).
Transmission electron microscopy studies. Naive, CM, EM, and 
EMRA CD8+ T cells were isolated and stimulated with anti-CD3 
(OKT3; 0.5 μg/ml) and 5 ng/ml IL-2 (Peprotech) for 3 days, with or 
without the p38 MAPK inhibitor BIRB 796. The cells were fixed in 2% 
paraformaldehyde, 1.5% glutaraldehyde with 0.1 m phosphate buf-
fer (pH 7.3). They were then osmicated in 1% OsO4 with 0.1 m phos-
phate buffer, dehydrated in a graded ethanol-water series, cleared 
in propylene oxide, and infiltrated with Araldite resin. Ultrathin sec-
tions were cut using a diamond knife, collected on 300 mesh grids, 
and stained with uranyl acetate and lead citrate. Cells were viewed in 
a Jeol 1010 transmission electron microscope (Jeol) and imaged using 
a Gatan Orius CCD camera (Gatan). Mitochondrial volume density 
(calculated as the percentage of CD8+ T cell volume occupied by mito-
chondria) was determined from electron microscopic images using a 
point-counting method with a grid generated by Image J: the grid was 
drawn on the image, and the number of intersection points that fell on 
mitochondria was determined.
Metabolic assays. OCR and ECAR were measured in the CD8+ T 
cell subsets after stimulation with anti-CD3 and 5 ng/ml IL-2 either 
overnight or for 3 days, with or without 500 nM BIRB 796. The assay 
was performed in RPMI without phenol red and carbonate buffer 
(Sigma-Aldrich) containing 25 mM glucose, 2 mM l-glutamine, and 
1 mM pyruvate. The metabolic stress test was performed using 1 μM 
oligomycin, 1.5 μM fluorocarbonyl cyanide phenylhydrazone (FCCP), 
100 nM rotenone, and 1 μM antimycin A (Seahorse Bioscience) with 
the XF-24 Extracellular Flux Analyzer (Seahorse Bioscience).
Inhibition of p38 signaling. Signaling through p38 MAPK on sorted 
CD27/CD45RA-defined CD8+ T cell subsets was blocked by adding 
the small-molecule p38 inhibitor BIRB 796, which blocks the activity 
of all forms of the molecule. CD8+ T cell subsets were incubated with 
500 nM BIRB 796 for 1 hour prior to stimulation with anti-CD3 (OKT3; 
0.5 μg/ml) and 5 ng/ml rhIL-2 (13). 0.1% DMSO was used as a control.
Assessment of autophagy. Autophagy was investigated using Image-
Stream. PBMCs were incubated with or without BIRB 796 and the inhib-
itors E64d and pepstatin A (Sigma-Aldrich; 10 μg/ml each) to induce 
autophagy for 2 hours. Subsequently, PBMCs were stained with the 
lysosomal marker Lyso-ID (Enzo Life Sciences); surface stained with 
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